Conference abstractPublished 27 Mar 2021

A targeted drug delivery nanosystem to hepatocellular carcinoma

Authors: Henrique Faneca

Journal of Cognitive Neuropsychology

Volume 5 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hepatocellular Carcinoma (HCC) is one of the major frequent cause of cancer-related mortality worldwide. Combination of different chemotherapeutics drugs may offer advantages for the treatment of HCC. Targeted hepatocellular carcinoma therapy was carried out to improve the efficacy of liver cancer treatment. The purpose of this study was to design an N-acetylgalactosamine (NAcGal) modified and pH sensitive doxorubicin (DOX) prodrug (NAcGal-DOX) for the construction of lipid nanoparticles (LNPs)

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Cognitive Neuropsychology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cognitive Neuropsychology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Henrique Faneca”